EUN1:F:F-iShares STOXX Europe 50 UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 46.175

Change

0.00 (0.00)%

Market Cap

USD 0.66B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-07-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.05 (+0.17%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.61 (+1.21%)

USD 112.01B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.26 (+0.05%)

USD 94.11B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.14 (+0.25%)

USD 93.50B
SXRZ:F iShares VII PLC - iShares Nikk..

-0.55 (-0.23%)

USD 56.46B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.03 (+0.18%)

USD 52.79B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.03 (-0.03%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

N/A

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

+0.01 (+0.13%)

USD 39.38B
0ZC:F Zscaler Inc

-1.14 (-0.65%)

USD 37.92B

ETFs Containing EUN1:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.98% 66% D+ 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.98% 62% D 58% F
Trailing 12 Months  
Capital Gain 12.68% 57% F 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.68% 54% F 56% F
Trailing 5 Years  
Capital Gain 41.38% 63% D 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 41.38% 63% D 52% F
Average Annual (5 Year Horizon)  
Capital Gain 8.03% 71% C- 68% D+
Dividend Return 8.03% 69% C- 62% D
Total Return N/A 18% F 19% F
Risk Return Profile  
Volatility (Standard Deviation) 10.63% 61% D- 84% B
Risk Adjusted Return 75.56% 91% A- 91% A-
Market Capitalization 0.66B 66% D+ 53% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.